About N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide
N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide (PubChem CID 95906928) has the molecular formula C20H21N3O2
and a molecular weight of 335.41 g/mol. Its IUPAC name is N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide.
Analyze N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide?
The IUPAC name of N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide (CID 95906928) is N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide.
What is the SMILES notation for N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide?
The canonical SMILES for N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide is Cc1nnc(-c2cccc(C(=O)N(C)C[C@H](C)c3ccccc3)c2)o1.
What is the InChIKey of N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide?
The InChIKey is QDVDLESJHYVLEB-AWEZNQCLSA-N. The full InChI is InChI=1S/C20H21N3O2/c1-14(16-8-5-4-6-9-16)13-23(3)20(24)18-11-7-10-17(12-18)19-22-21-15(2)25-19/h4-12,14H,13H2,1-3H3/t14-/m0/s1.
What are the key properties of N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide?
N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide has a molecular weight of 335.41 g/mol, XLogP of 3.92, 5 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-N-[(2R)-2-phenylpropyl]benzamide is sourced from PubChem (CID 95906928), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).